The Central Government's Pradhan Mantri Bhartiya Jan Aushadhi Pariyojana serves economically disadvantaged populations in Madhya Pradesh's Guna district through affordable healthcare access. Jan Aushadhi Kendras operate near district hospitals, distributing generic medications at substantially reduced costs compared to branded alternatives. The program targets families struggling with chronic medical conditions that previously consumed large portions of household income. Local residents express gratitude for the financial relief this initiative provides their communities. Healthcare expenses have decreased dramatically for households managing multiple patients with serious health conditions.
Generic medicines available through these centers cost 50 to 80 percent less than commercial brands, generating approximately 38,000 crore rupees in public savings. The scheme encompasses 2,110 medications and 315 surgical supplies across major therapeutic categories like cardiovascular, cancer treatment, diabetes management, and infection control. Government officials plan to expand from the current 850 locations to 25,000 centers nationwide. This expansion will create additional employment opportunities while extending healthcare access to underserved populations. The program demonstrates effective public policy addressing both economic hardship and medical accessibility challenges.
Generic medicines available through these centers cost 50 to 80 percent less than commercial brands, generating approximately 38,000 crore rupees in public savings. The scheme encompasses 2,110 medications and 315 surgical supplies across major therapeutic categories like cardiovascular, cancer treatment, diabetes management, and infection control. Government officials plan to expand from the current 850 locations to 25,000 centers nationwide. This expansion will create additional employment opportunities while extending healthcare access to underserved populations. The program demonstrates effective public policy addressing both economic hardship and medical accessibility challenges.
